-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LgvpRJrv3nAAemv+gz7AwviGn1FAP1wqa2nnefjqof2A2nwI9yJdH19F4k5qxMeU mWH6/Tw+RC4kSMAJ5kwfDg== 0001463570-09-000001.txt : 20090508 0001463570-09-000001.hdr.sgml : 20090508 20090508134124 ACCESSION NUMBER: 0001463570-09-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090508 DATE AS OF CHANGE: 20090508 EFFECTIVENESS DATE: 20090508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palyon Medical Corp CENTRAL INDEX KEY: 0001463570 IRS NUMBER: 061700008 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-130784 FILM NUMBER: 09809225 BUSINESS ADDRESS: STREET 1: 250 W. 57TH STREET, SUITE 1716 CITY: NEW YORK STATE: NY ZIP: 10107 BUSINESS PHONE: 212-333-2050 MAIL ADDRESS: STREET 1: 250 W. 57TH STREET, SUITE 1716 CITY: NEW YORK STATE: NY ZIP: 10107 D 1 primary_doc.xml X0301 D LIVE 0001463570 Palyon Medical Corp 250 W. 57TH STREET, SUITE 1716 NEW YORK NY 10107 212-333-2050 None DE Corporation true 2009 David Present 250 West 57th Street Suite 1716 New York NY 10107 Executive Officer Director Gregory David 250 West 57th Street Suite 1716 New York NY 10107 Executive Officer Director Cherine Plumaker 250 West 57th Street Suite 1716 New York NY 10107 Executive Officer Michael Liang 250 West 57th Street Suite 1716 New York NY 10107 Director Daniel Omstead 250 West 57th Street Suite 1716 New York NY 10107 Director Aidan King 250 West 57th Street Suite 1716 New York NY 10107 Director Glen Kashuba 250 West 57th Street Suite 1716 New York NY 10107 Director Biotechnology Decline to Disclose 06 false 2009-04-27 false true false 0 Rockport Venture Securities, LLC 113748 Rockport Venture Securities, LLC 113748 275 Cabot Street Suite 10 Beverly MA 01915 IL MA NY 24000000 21000000 3000000 false 9 1440000 true 0 $1,260,000 was paid in connection with the sale with the balance to be paid after the sale of the remaining securities in cash plus warrants to purchase common stock. 47916 The issuer will use the proceeds for general corporate and working capital purposes, including the payment of salary to employees, including salary owed as of the date of the sale. false Palyon Medical Corp David Present David Present President 2009-05-08 -----END PRIVACY-ENHANCED MESSAGE-----